Stephanie Brecher
@Nea Management Company, Llc
Latest period2024 - Q3ReportedManaged Assets$1.836BTotal holdings42
Assets growth rate38.12%Assets growth rate (2-Q avg)10.31%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Nea Management Company, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 42 positions.
Assets under management
The assets under management (AUM) of Nea Management Company, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.836B in assets, with a quarterly growth rate of 38.12% and a 2-quarter average growth rate of 10.31%. The portfolio is managed by Stephanie Brecher, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
GLUEMonte Rosa Therapeutics Inc
| 2.23% | $40.769M 7.692M shares@ $5.3 avg price | |
TRVITrevi Therapeutics Inc
| 2.07% | $37.977M 11.37M shares@ $3.35 avg price | |
KRROKorro Bio Inc
| 1.99% | $36.454M 1.091M shares@ $33.42 avg price | |
PHATPhathom Pharmaceuticals Inc
| 1.94% | $35.44M 1.96M shares@ $18.09 avg price | |
AUPHAurinia Pharmaceuticals Inc
| 1.59% | $29.099M 3.97M shares@ $7.33 avg price | |
CVRXCvrx Inc
| 1.14% | $20.884M 2.371M shares@ $8.81 avg price | |
BDTXBlack Diamond Therapeutics Inc
| 1.06% | $19.352M 4.449M shares@ $4.36 avg price | |
CELCCelcuity Inc
| 1.02% | $18.638M 1.25M shares@ $14.92 avg price | |
GOSSGossamer Bio Inc
| 0.98% | $17.912M 18.093M shares@ $1.0 avg price | |
ADAPAdaptimmune Therapeutics Plc
| 0.89% | $16.226M 17.08M shares@ $0.95 avg price |